Russia awaits the visit of a team of specialists from the World Health Organization (WHO) in December to work in the Sputnik V review with a view to its possible inclusion in the emergency use listsaid on Wednesday the head of the Russia Direct Investment Fund (RDIF) that sells the vaccine.
Inclusion on the list would be a major step forward for Sputnik V, matching the approval that the who it has already granted eight other vaccines.
The process of Sputnik has gone on throughout the year with multiple requests from the who for data submission and various inspections of manufacturing sites. The RDIF has said that it awaits the approval of the who by the end of the year.
Coronavirus cases in Europe grow at a record rate, wake-up call for America?
When asked for a comment, a spokesperson for the who said the organization met with the RDIF at the end of november “to discuss the need for additional data on the quality, safety and efficacy of the vaccine“.
The spokesperson said that the company had committed to submitting a “detailed roadmap for data submission” for the company. who could speed up your evaluation.